<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chatterjee J</submitter><funding>Vision Restoration Initiative</funding><funding>National Institutes of Health</funding><funding>Schnuck Markets</funding><funding>NIH HHS</funding><pagination>1579-1593</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12309722</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>27(6)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The intestinal microbiota regulates normal brain physiology and the pathogenesis of several neurological disorders. While prior studies suggested that this operates through immune cells, the underlying mechanisms remain unclear. Leveraging 2 well-characterized murine models of low-grade glioma occurring in the setting of the neurofibromatosis type 1 (NF1) cancer predisposition syndrome, we sought to determine the impact of the gut microbiome on optic glioma progression.&lt;h4>Methods&lt;/h4>Neurofibromatosis type 1 (Nf1)-mutant mice genetically engineered to develop optic pathway gliomas (Nf1OPG mice) by 3 months of age were reared under germ-free (GF) conditions, treated with specific cocktails of antibiotics, or given fecal matter transplants (FMTs). Intestinal microbial spe</pubmed_abstract><journal>Neuro-oncology</journal><pubmed_title>Intestinal Bacteroides drives glioma progression by regulating CD8+ T cell tumor infiltration.</pubmed_title><pmcid>PMC12309722</pmcid><funding_grant_id>R35NS097211</funding_grant_id><pubmed_authors>Chatterjee J</pubmed_authors><pubmed_authors>Schriefer LA</pubmed_authors><pubmed_authors>Aggarwal S</pubmed_authors><pubmed_authors>Campbell DE</pubmed_authors><pubmed_authors>Eligator T</pubmed_authors><pubmed_authors>Baldridge MT</pubmed_authors><pubmed_authors>Ouyang M</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Gutmann DH</pubmed_authors><pubmed_authors>Qi X</pubmed_authors><pubmed_authors>Rodgers R</pubmed_authors><pubmed_authors>Mu R</pubmed_authors><pubmed_authors>Bozeman SL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Intestinal Bacteroides drives glioma progression by regulating CD8+ T cell tumor infiltration.</name><description>&lt;h4>Background&lt;/h4>The intestinal microbiota regulates normal brain physiology and the pathogenesis of several neurological disorders. While prior studies suggested that this operates through immune cells, the underlying mechanisms remain unclear. Leveraging 2 well-characterized murine models of low-grade glioma occurring in the setting of the neurofibromatosis type 1 (NF1) cancer predisposition syndrome, we sought to determine the impact of the gut microbiome on optic glioma progression.&lt;h4>Methods&lt;/h4>Neurofibromatosis type 1 (Nf1)-mutant mice genetically engineered to develop optic pathway gliomas (Nf1OPG mice) by 3 months of age were reared under germ-free (GF) conditions, treated with specific cocktails of antibiotics, or given fecal matter transplants (FMTs). Intestinal microbial spe</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jul</publication><modification>2026-06-06T22:33:28.928Z</modification><creation>2026-06-06T03:10:42.832Z</creation></dates><accession>S-EPMC12309722</accession><cross_references><pubmed>39868555</pubmed><doi>10.1093/neuonc/noaf024</doi></cross_references></HashMap>